The team based at our MHRA-accredited facility has significant experience in First-in-Human trials with a strong focus on participant safety, risk management, and adding maximum value to your protocol through adaptive trial design.
Using our knowledge and expertise, we advise on enhancements to your protocol development and study design approach, ensuring quality is built in from the outset to enable efficient delivery of your early phase results.
Who We Are